Healthcare Royalty Partners has raised over $659 million for its fourth fund, according to an SEC filing. No target was listed in the document. The Stamford, Connecticut-based investment firm “purchases royalties and uses debt-like structures to invest in commercial or near-commercial stage life science assets,” according to its website.